Your browser doesn't support javascript.
loading
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria.
Kocatürk, Emek; Salman, Andaç; Cherrez-Ojeda, Ivan; Criado, Paulo Ricardo; Peter, Jonny; Comert-Ozer, Elif; Abuzakouk, Mohamed; Agondi, Rosana Câmara; Al-Ahmad, Mona; Altrichter, Sabine; Arnaout, Rand; Arruda, Luisa Karla; Asero, Riccardo; Bauer, Andrea; Ben-Shoshan, Moshe; Bernstein, Jonathan A; Bizjak, Mojca; Boccon-Gibod, Isabelle; Bonnekoh, Hanna; Bouillet, Laurence; Brzoza, Zenon; Busse, Paula; Campos, Regis A; Carne, Emily; Conlon, Niall; Criado, Roberta F; de Souza Lima, Eduardo M; Demir, Semra; Dissemond, Joachim; Dogan Günaydin, Sibel; Dorofeeva, Irina; Ensina, Luis Felipe; Ertas, Ragip; Ferrucci, Silvia Mariel; Figueras-Nart, Ignasi; Fomina, Daria; Franken, Sylvie M; Fukunaga, Atsushi; Giménez-Arnau, Ana M; Godse, Kiran; Gonçalo, Margarida; Gotua, Maia; Grattan, Clive; Guillet, Carole; Inomata, Naoko; Jakob, Thilo; Karakaya, Gul; Kasperska-Zajac, Alicja; Katelaris, Constance H; Kosnik, Mitja.
Affiliation
  • Kocatürk E; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey.
  • Salman A; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, Marmara University School of Medicine, Istanbul, Turkey.
  • Cherrez-Ojeda I; Urticaria Center of Reference and Excellence (UCARE), School of Medicine, Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador and RespiraLab, Research, Guayaquil, Ecuador.
  • Criado PR; Urticaria Center of Reference and Excellence (UCARE), Faculdade de Medicina do ABC, Santo André, Brazil.
  • Peter J; Alergoskin Alergia e Dermatologia SS ltda, Santo André, Brazil.
  • Comert-Ozer E; UCARE Center, São Paulo, Brazil.
  • Abuzakouk M; Urticaria Center of Reference and Excellence (UCARE), Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, 7925, South Africa.
  • Agondi RC; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, Marmara University School of Medicine, Istanbul, Turkey.
  • Al-Ahmad M; Urticaria Center of Reference and Excellence (UCARE), Cleveland Clinic Abu Dhabi, UAE.
  • Altrichter S; Urticaria Center of Reference and Excellence (UCARE), University of São Paulo, São Paulo, Brazil.
  • Arnaout R; Urticaria Center of Reference and Excellence (UCARE), Microbiology Department, Faculty of Medicine, Kuwait University, Safat, Kuwait.
  • Arruda LK; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Asero R; Urticaria Center of Reference and Excellence (UCARE), King Faisal Specialist Hospital & Research Center, Al Faisal University, Riyadh, Saudi Arabia.
  • Bauer A; Urticaria Center of Reference and Excellence (UCARE), Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Ben-Shoshan M; Urticaria Center of Reference and Excellence (UCARE), Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, Italy.
  • Bernstein JA; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, University Allergy Center, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany.
  • Bizjak M; Urticaria Center of Reference and Excellence (UCARE), Division of Allergy, Immunology and Dermatology, Department of Pediatrics, McGill University Health Center, Montreal, QC, Canada.
  • Boccon-Gibod I; Urticaria Center of Reference and Excellence (UCARE), University of Cincinnati College of Medicine, Division of Immunology, Rheumatology and Allergy, Cincinnati, USA.
  • Bonnekoh H; Urticaria Center of Reference and Excellence (UCARE), Division of Allergy, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
  • Bouillet L; Urticaria Center of Reference and Excellence (UCARE), Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble, France.
  • Brzoza Z; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Busse P; Autoinflammation Reference Center Charité (ARC2), Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Campos RA; Urticaria Center of Reference and Excellence (UCARE), Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble, France.
  • Carne E; Urticaria Center of Reference and Excellence (UCARE), Department of Internal Medicine with Division of Allergology, Institute of Medical Sciences, University of Opole, Opole, Poland.
  • Conlon N; Urticaria Center of Reference and Excellence (UCARE), Division of Clinical Immunology and Allergy, Icahn School at Mount Sinai, New York, NY, USA.
  • Criado RF; Urticaria Center of Reference and Excellence (UCARE), Universidade Federal da Bahia, Salvador, Brazil.
  • de Souza Lima EM; Serviço de Imunologia, Hospital das Clínicas Professor Edgard Santos, Salvador, Brazil.
  • Demir S; Urticaria Center of Reference and Excellence (UCARE), University Hospital of Wales, Cardiff, UK.
  • Dissemond J; Urticaria Center of Reference and Excellence (UCARE), Department of Immunology, St James's Hospital and Trinity College, Dublin, Ireland.
  • Dogan Günaydin S; Urticaria Center of Reference and Excellence (UCARE), Faculdade de Medicina do ABC (FMABC), Santo André, Brazil.
  • Dorofeeva I; Urticaria Center of Reference and Excellence, (UCARE), Faculdade de Ciências, Médicas e da Saúde de Juiz de Fora (SUPREMA), Hospital Maternidade Therezinha de Jesus, Minas Gerais, Brazil.
  • Ensina LF; Urticaria Center of Reference and Excellence (UCARE), Division of Allergy, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Ertas R; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, Venereology and Allergology, University of Essen, Essen, Germany.
  • Ferrucci SM; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology and Venereology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Figueras-Nart I; Urticaria Center of Reference and Excellence (UCARE), Department of Allergy and Immunotherapy, Institute of Immunology, FMBA of Russia, Moscow, Russia.
  • Fomina D; Urticaria Center of Reference and Excellence (UCARE), Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil.
  • Franken SM; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, Kayseri City Education and Research Hospital, Kayseri, Turkey.
  • Fukunaga A; Urticaria Center of Reference and Excellence (UCARE), Ambulatorio di Dermatologia Allergologica e Professionale, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Giménez-Arnau AM; Urticaria Center of Reference and Excellence (UCARE), The Dermatology Department of the Hospital de Bellvitge, Universitat de Barcelona, Barcelona, Spain.
  • Godse K; Urticaria Center of Reference and Excellence (UCARE), Center of Allergy and Immunology, Moscow Ministry of Healthcare, Moscow, Russia.
  • Gonçalo M; Department of Allergology and Clinical Immunology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • Gotua M; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, Amsterdam UMC, Amsterdam, The Netherlands.
  • Grattan C; Urticaria Center of Reference and Excellence (UCARE), Division of Dermatology, Kobe University, Graduate School of Medicine, Kobe, Japan.
  • Guillet C; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, Hospital del Mar, IMIM, Universitat Autònoma, Barcelona, Spain.
  • Inomata N; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, D Y. Patil University School of Medicine, Mumbai, India.
  • Jakob T; Urticaria Center of Reference and Excellence (UCARE), Centro Hospitalar Universitário Coimbra and Faculty of Medicine, University of Coimbra, Clinica de Dermatologia, Coimbra, Portugal.
  • Karakaya G; Urticaria Center of Reference and Excellence (UCARE, Center of Allergy and Immunology, Tbilsi, Georgia.
  • Kasperska-Zajac A; Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology, Guys & St Thomas' Hospital, London, UK.
  • Katelaris CH; Urticaria Center of Reference and Excellence (UCARE), Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
  • Kosnik M; Urticaria Center of Reference and Excellence (UCARE), Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Allergy ; 76(3): 816-830, 2021 03.
Article in En | MEDLINE | ID: mdl-33284457
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chronic Urticaria / SARS-CoV-2 / COVID-19 Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Allergy Year: 2021 Document type: Article Affiliation country: Turquía
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chronic Urticaria / SARS-CoV-2 / COVID-19 Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Allergy Year: 2021 Document type: Article Affiliation country: Turquía